Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
See Latest ArticlesTreatments for psoriasis and the risk of malignancy
Journal of the American Academy of Dermatology, 06/05/09
Patel RV et al. - Many of the therapies for moderate to severe psoriasis, including PUVA, traditional systemic therapies, and some biologic therapies, may increase the risk of malignancy. Appropriate patient counseling and selection, as well as clinical follow-up, are necessary to maximize safety with these agents.
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Childhood melanoma
Clinics in Dermatology, 11/04/09
Unusual variants of malignant melanoma
Clinics in Dermatology, 11/06/09
A Multimarker Prognostic Assay for Primary Cutaneous Melanoma
Clinical Cancer Research, 11/06/09
Today in Psoriasis...keeping you current
Receive free subspecialty "5-minute updates" via email
A practical approach to using methotrexate
Dermatology in Practice, 10/09/09
Topical tazarotene vs. coal tar in stable plaque psoriasis
Clinical and Experimental Dermatology, 10/28/09
Pediatric psoriasis: an update
Therapeutics and Clinical Risk Management, 10/22/09
Sponsor
Article Search
Sponsor